Ionis, AstraZeneca get FDA approval for rare genetic disease treatment
Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the U.S. Food and Drug Administration for ...
Read moreTag: Product/Service Approvals
Bitcoin and ether rally on ETF optimism, sparking hope of a ‘crypto spring’
Welcome back to Distributed Ledger. This is Frances Yue, reporter at MarketWatch. Bitcoin BTCUSD, +0.00% had another leg up this ...
Read more
Better Therapeutics stock surges after FDA approves smartphone-based diabetes treatment
Better Therapeutics Inc. shares surged in the extended session Monday after the digital therapeutics company got Food and Drug Administration ...
Read moreEisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
Eisai shares 4523, +7.37% rose sharply Thursday morning after the U.S. Food and Drug Administration’s review memo on Leqembi raised ...
Read more
